Your browser doesn't support javascript.
loading
Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.
Shaffer, Seth R; Erondu, Amarachi I; Traboulsi, Cindy; Rai, Victoria; Krugliak Cleveland, Noa; Israel, Amanda; Christensen, Britt; Rubin, David T.
Afiliação
  • Shaffer SR; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago,Illinois, USA.
  • Erondu AI; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago,Illinois, USA.
  • Traboulsi C; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago,Illinois, USA.
  • Rai V; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago,Illinois, USA.
  • Krugliak Cleveland N; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago,Illinois, USA.
  • Israel A; Michael Garron Hospital, Toronto, Ontario, Canada.
  • Christensen B; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, Australia.
  • Rubin DT; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Australia.
Inflamm Bowel Dis ; 28(4): 553-559, 2022 03 30.
Article em En | MEDLINE | ID: mdl-34037230
BACKGROUND: Complete histologic normalization is associated with improved clinical outcomes in ulcerative colitis (UC). However, it is currently unknown what effect achieving histologic normalization has on the development of dysplasia. METHODS: We performed a retrospective analysis of 495 patients with a confirmed diagnosis of UC from a tertiary center. Patients were categorized according to the best histologic assessment they had during their disease course: histologic normalization, histologic quiescence, or persistent histologic activity. We assessed dysplasia rates in these patient groups after achieving histologic normalization or histologic quiescence, or 8 years after UC diagnosis in those with persistent histologic activity. Kaplan-Meier graphs and Cox regression analyses were performed to estimate this effect. RESULTS: The incidence rate of dysplasia development after achieving histologic normalization was statistically significantly less when compared with the incidence rate after achieving histologic quiescence (P = 0.001) and in those with persistent histologic activity 8 years after UC diagnosis (P = 0.033). In multivariate analysis, at any point throughout UC duration, dysplasia development was statistically lower in those with histologic normalization (adjusted hazard ratio [aHR], 0.32; 95% confidence interval [CI], 0.13-0.81) but not in those with histologic quiescence (aHR, 0.52; 95% CI, 0.25-1.10), compared with those with persistent histologic inflammation. When assessing the time after achieving histologic normalization, histologic quiescence, or 8 years post UC diagnosis in those with persistent histologic activity, we found that patients with histologic normalization had a subsequent decreased risk of developing dysplasia (aHR, 0.09; 95% CI, 0.01-0.72), compared with patients without normalization. CONCLUSIONS: Histologic normalization is associated with a decreased risk in patients with UC of developing subsequent dysplasia, compared with patients without histologic normalization. These findings have implications for surveillance intervals.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Inflamm Bowel Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Inflamm Bowel Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos